NRXP NRx Pharmaceuticals, Inc.
Price Chart
Executive Summary
NRx Pharmaceuticals closed an underwritten public offering of common stock at $3.50 per share, raising approximately $22.3 million in gross proceeds. The proceeds will be used for working capital and general corporate purposes to support the company's clinical-stage pipeline for CNS disorders.
Key Financial Metrics
Actionable Insight
The dilutive offering at a 2.8% discount to the current price (assuming $3.60 close) adds overhang. Monitor for further dilution if the shelf is tapped again. The company's cash runway extends but at the cost of shareholder value.
Key Facts
- Closed underwritten public offering of common stock at $3.50 per share
- Gross proceeds of approximately $22.3 million
- Proceeds to be used for working capital and general corporate purposes
- BTIG and Lucid Capital Markets acted as bookrunners
- Offering made under effective shelf registration statement on Form S-3 (File No. 333-288205)
Financial Impact
Dilution of approximately 6.37 million shares at $3.50 per share, representing about 15% of pre-offering shares outstanding (based on $147M market cap / $3.50 = 42M shares pre-offering). Gross proceeds of $22.3 million.
Risk Factors
- Further dilution from remaining shelf capacity
- Clinical-stage pipeline with no approved products; regulatory and commercial risks
- Potential for additional capital raises given operating losses
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3307137 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 5, 2026
7d ago
|
Press Release
| $4.12 awaiting T+1 | awaiting T+1 | — | $3.84 (−6.80%) |
|
Jun 4, 2026
8d ago
|
Press Release
| $4.05 awaiting T+1 | awaiting T+1 | — | $3.84 (+5.19%) |
|
Jun 3, 2026
9d ago
|
Press Release
| $4.05 $4.05 | · 0.00% | ▲ +0.40% | $3.84 (+5.19%) |
|
Jun 2, 2026
10d ago
|
Press Release
| $4.05 $4.05 | · 0.00% | ▲ +0.41% | $3.84 (+5.19%) |
|
May 18, 2026
25d ago
|
Press Release
| $3.12 $3.03 | ▼ −2.73% | ▼ −2.08% | $3.84 (+23.27%) |
|
May 14, 2026
29d ago
|
Press Release
| $3.21 $3.28 | ▲ +2.18% | ▲ +3.41% | $3.84 (+19.63%) |
|
Mar 30, 2026
10w ago
|
Press Release
| $2.09 $2.13 | ▲ +1.91% | ▼ −0.98% | $3.84 (+83.73%) |
|
Mar 19, 2026
12w ago
|
Press Release
| $1.84 $1.85 | ▲ +0.54% | ▲ +2.29% | $3.84 (+108.70%) |
|
Feb 24, 2026
15w ago
|
DEFA14A
| $1.91 $1.93 | ▲ +1.05% | ▲ +1.59% | $3.84 (+101.05%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access